OJJAARA 100/150/200 MG TAB (MOMELOTINIB)
Price
FAQ's
Details
Patients Stories
Important Guide
Ojjaara (Momelotinib) offers a targeted treatment option for adults with intermediate or high-risk myelofibrosis accompanied by anemia. Its unique mechanism addresses both disease progression and anemia-related symptoms. However, due to potential risks, including hematologic toxicity and cardiovascular events, careful patient selection and regular monitoring are essential